GLP-1 receptor agonists such as semaglutide and liraglutide are licensed for type 2 diabetes mellitus and, in specific formulations, for weight management in carefully selected patients meeting NICE criteria
When taken as directed and monitored by a provider, it can be an effective tool for patients who struggle with hunger, cravings, and emotional eating
Social media groups may be moderated, restricted, or discontinued at any time and are subject to platform-specific rules
Our pharmacy partners use reduced glutathione (GSH) in stabilized formulations for maximum efficacy
The lyophilised compound remains stable until its expiry date when stored properly
Ethical approval of the study was obtained from Shanghai Ninth Peoples Hospital, Shanghai JiaoTong University School of Medicine.All patients provided written informed consent